Format

Send to

Choose Destination
Asia Pac J Ophthalmol (Phila). 2016 Jul-Aug;5(4):265-71. doi: 10.1097/APO.0000000000000227.

Retinitis Pigmentosa: Progress and Perspective.

Author information

1
From the State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China.

Abstract

Retinitis pigmentosa is the most common form of hereditary retinal degeneration causing blindness. Great progress has been made in the identification of the causative genes. Gene diagnosis will soon become an affordable routine clinical test because of the wide application of next-generation sequencing. Gene-based therapy provides hope for curing the disease. Investigation into the molecular pathways from mutation to rod cell death may reveal targets for developing new treatment. Related progress with existing systematic review is briefly summarized so that readers may find the relevant references for in-depth reading. Future trends in the study of retinitis pigmentosa are also discussed.

PMID:
27488069
DOI:
10.1097/APO.0000000000000227
[Indexed for MEDLINE]
Free full text

Supplemental Content

Full text links

Icon for Asia-Pacific Academy of Ophthalmology
Loading ...
Support Center